600223.SS
600223.SS
CNE000001147
LUSHANG FREDA PHARMACEUTICAL CO
Loading chart...

Company Profile

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.

Related stocks

000042.SZ
000042.SZ • China
CENTRALCON HOLDING
8.6 CNY
855.54M USD 1Y +6.3%
600743.SS
600743.SS • China
BEIJING HUAYUAN XINHANG HOLDING
2.36 CNY
828.49M USD 1Y +12.9%
600708.SS
600708.SS • China
BRIGHT REAL ESTATE GROUP CO LIM
3.09 CNY
1.03B USD 1Y -14.2%
600736.SS
600736.SS • China
SUZHOU NEW DISTRICT HI TECH IND
6.48 CNY
1.12B USD 1Y +7.8%
600748.SS
600748.SS • China
SHANGHAI INDUSTRIAL DEVELOPMENT
4.11 CNY
1.13B USD 1Y -17.6%
000718.SZ
000718.SZ • China
SUC
2.09 CNY
949.03M USD 1Y -20.2%
601588.SS
601588.SS • China
BEIJING NORTH STAR CO
1.83 CNY
921.99M USD 1Y -4.2%
000797.SZ
000797.SZ • China
CHINA WUYI
2.67 CNY
627.55M USD 1Y -1.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
39.6% p.a.
Max Drawdown (5Y)
-67.2%
Sharpe Ratio (5Y)
-0.48
Beta Factor
0.82
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (39.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.1% in the extended horizon.
ende